IAMA Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $16.5M

  • Investors
  • 4

IAMA Therapeutics General Information

Description

Developer of a neuroscience drug discovery platform designed to provide personalized treatments for patients suffering from untreatable neurological conditions. The company's platform can significantly alleviate the learning and memory difficulties typical of patients with Down syndrome as well as the more significant behavioral manifestations of the autism spectrum, enabling patients to get treatment for their disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Filippo Turati, 2
  • 16128 Genoa
  • Italy
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Via Filippo Turati, 2
  • 16128 Genoa
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IAMA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 16-Apr-2025 $16.5M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 29-Mar-2022 Completed Pre-Clinical Trials
To view IAMA Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

IAMA Therapeutics Patents

IAMA Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025257786-A1 Benzoimidazole derivatives as nkcc1 inhibitors Pending 13-Jun-2024
EP-4836783-A1 Modulators of intracellular chloride concentration Pending 04-Jan-2024
WO-2025146650-A1 Modulators of intracellular chloride concentration Inactive 04-Jan-2024
AU-2024258174-A1 Process for the preparation of sulfamoylbenzoic acid derivatives Pending 18-Apr-2023
EP-4698512-A1 Process for the preparation of sulfamoylbenzoic acid derivatives Pending 18-Apr-2023 C07C303/40
To view IAMA Therapeutics’s complete patent history, request access »

IAMA Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IAMA Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Indaco Venture Partners Venture Capital Minority
Tech and Biomedical Foundation Venture Capital Minority
CDP Venture Capital (Rome) Venture Capital Minority
Claris Ventures Venture Capital Minority
To view IAMA Therapeutics’s complete investors history, request access »

IAMA Therapeutics FAQs

  • When was IAMA Therapeutics founded?

    IAMA Therapeutics was founded in 2021.

  • Where is IAMA Therapeutics headquartered?

    IAMA Therapeutics is headquartered in Genoa, Italy.

  • What is the size of IAMA Therapeutics?

    IAMA Therapeutics has 10 total employees.

  • What industry is IAMA Therapeutics in?

    IAMA Therapeutics’s primary industry is Drug Discovery.

  • Is IAMA Therapeutics a private or public company?

    IAMA Therapeutics is a Private company.

  • What is IAMA Therapeutics’s current revenue?

    The current revenue for IAMA Therapeutics is .

  • How much funding has IAMA Therapeutics raised over time?

    IAMA Therapeutics has raised $25.3M.

  • Who are IAMA Therapeutics’s investors?

    Indaco Venture Partners, Tech and Biomedical Foundation, CDP Venture Capital (Rome), and Claris Ventures have invested in IAMA Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process